Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Directors' Dealing

27 Feb 2020 11:22

RNS Number : 3668E
Craven House Capital PLC
27 February 2020
 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

Craven House Capital plc

 

("Craven House" or the "Company")

 

Issue of Equity and Directors' Dealing

 

 

The Company announces that Balbir Bindra and Calum Morrison have each been issued 4,904 new ordinary shares ("New Ordinary Shares") as per the terms of their respective appointment letters.

 

As a result of this issue, Balbir Bindra will hold 14,440 Ordinary Shares, representing 0.5% per cent of the Company's issued share capital.

 

As a result of this issue, Calum Morrison will hold 7,356 Ordinary Shares, representing 0.2% per cent of the Company's issued share capital.

 

 

Admission of the New Ordinary Shares to trading on AIM and Total Voting Rights

 

Application will be made for admission of the 9,808 New Ordinary Shares to be issued on the AIM Market of the London Stock Exchange, which is expected to take place at 8.00 a.m. on or around 4 March 2020 ("Admission").

 

The New Ordinary Shares will, when issued, be credited as fully paid and will rank equally in all respects with the existing Ordinary Shares, including the right to receive any dividend or other distribution declared, made or paid after Admission.

 

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following Admission will consist of 3,063,589 Ordinary Shares of $1.00 with voting rights attached (one vote per Ordinary Share). There are no Ordinary Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the DTRs.

 

~ Ends ~

 

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.Sparkadvisorypartners.com

 

 

 

 

Tel: 0203 368 3550

 

 

 

About Craven House Capital:

 

The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.

 

 

PDMR Notifications

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Balbir Bindra

2. Calum Morrison

2.

Reason for the Notification

a)

Position/status

1. Non-Executive Director

2. Non-Executive Director

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Craven House Capital PLC

b)

LEI

213800NY9RH8O1B72D27

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of $1.0

Identification code

GB00BD4FQ360

b)

Nature of the Transaction

Issue of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. $0

2. $0

1. 4,904

2. 4,904

d)

Aggregated information

Aggregated volume / price

Aggregate volume: 9,808

Aggregated price: $0

e)

Date of the transaction

27 February 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPPUUPPUPUGGM
Date   Source Headline
2nd Mar 20104:45 pmPRNAnnual Financial Report
26th Feb 20102:38 pmRNSInterim Results
18th Feb 20107:00 amPRNRe Agreement Investment Advisory
8th Feb 20104:46 pmRNSDirectorate Change
29th Jan 20102:34 pmRNSTotal Voting Rights
13th Jan 20103:43 pmRNSHolding(s) in Company
29th Dec 200911:43 amRNSInvesting Policy
22nd Oct 20097:00 amRNSDirectorate Change
16th Oct 20092:30 pmRNSCapitalisation of Loan
6th Oct 20094:57 pmRNSHolding(s) in Company
5th Oct 20092:45 pmRNSDirectors' Shareholding
28th Sep 200911:26 amRNSDirector Resignation
14th Sep 20094:39 pmPRNHalf-yearly Report
11th Sep 20093:39 pmRNSDirectorate Change
11th Sep 20093:26 pmRNSAGM Statement
31st Jul 200911:51 amRNSNotice of AGM
31st Jul 20097:00 amRNSAnnual Report
2nd Jun 200910:30 amRNSHoldings in Company
29th May 20094:04 pmRNSDirector Shareholding
26th May 20091:15 pmRNSChange of Adviser
20th May 20094:50 pmRNSDirector/PDMR Shareholding
20th May 20094:47 pmRNSre: Sub-Division of Shares
20th May 20097:00 amRNSDirectorate Change
15th May 20092:31 pmRNSTrading Statement
13th May 20099:43 amPRNIncrease in Performance Fees
11th May 20097:00 amRNSRestoration - Medsea Estates Group plc
8th May 20095:15 pmRNSChange of Adviser
30th Apr 20092:37 pmRNSResult of EGM
27th Apr 200911:44 amRNSAddendum and Appt of Director
22nd Apr 200910:30 amRNSDirectorate Change
6th Apr 200912:10 pmRNSResignation of Nomad and Broker
6th Apr 200912:10 pmRNSSuspension - Medsea Estates Group plc
19th Mar 20093:48 pmRNSTrading Update- Replacement
19th Mar 200911:45 amRNSTrading Update
1st Dec 200810:20 amRNSDirectorate Change
10th Nov 200810:45 amRNSUpdate re proposed delisting
30th Sep 20084:17 pmRNSTotal Voting Rights
30th Sep 20087:00 amRNSInterim Results
8th Sep 200811:00 amRNSProposed cancellation of AIM
4th Sep 200811:37 amRNSResult of AGM
1st Sep 20083:06 pmRNSDirectorate Change
13th Aug 20089:17 amRNSNotice of AGM
4th Jul 200810:47 amRNSDirector/PDMR Shareholding
30th Jun 20084:00 pmRNSAnnual Report and Accounts
30th Jun 20087:00 amRNSFinal Results
30th Apr 200811:03 amRNSUpdate re Report & Accounts
18th Feb 20083:00 pmRNSDirector/PDMR Shareholding
13th Feb 20083:04 pmRNSTrading Statement
23rd Nov 20077:01 amRNSDirectorate Change
28th Sep 20077:05 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.